Howard Marks – INDV history
- Issuer:
- Indivior Pharmaceuticals Inc
- Quarters tracked:
- 10 (Q1 2024 → Q1 2026)
- Current shares:
- 212,875,428
- Current value:
- $6.98M
- Peak shares:
- 257,785,398 (Q3 2025)
- Overall change:
- +6252%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 212,875,428 | $6.98M | $0.03 | +205,766,784 | +2895% |
| Q4 2025 | 7,108,644 | $255.06M | $35.88 | 0 | 0% |
| Q4 2025 | 7,108,644 | $255.06M | $35.88 | -250,676,754 | -97% |
| Q3 2025 | 257,785,398 | $10.69M | $0.04 | +246,776,273 | +2242% |
| Q2 2025 | 11,009,125 | $162.28M | $14.74 | 0 | 0% |
| Q1 2025 | 11,009,125 | $103.45M | $9.40 | +2,275,577 | +26% |
| Q4 2024 | 8,733,548 | $112.00B | $12824.58 | -788,432 | -8% |
| Q3 2024 | 9,521,980 | $94.07B | $9879.04 | +5,028,807 | +112% |
| Q2 2024 | 4,493,173 | $70.43B | $15674.84 | +1,141,937 | +34% |
| Q1 2024 | 3,351,236 | $71.71B | $21399.46 | — | NEW |